Recombinant multi-species UBE3A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UBE3A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an E3 ubiquitin-protein ligase, part of the ubiquitin protein degradation system. This imprinted gene is maternally expressed in brain and biallelically expressed in other tissues. Maternally inherited deletion of this gene causes Angelman Syndrome, characterized by severe motor and intellectual retardation, ataxia, hypotonia, epilepsy, absence of speech, and characteristic facies. The protein also interacts with the E6 protein of human papillomavirus types 16 and 18, resulting in ubiquitination and proteolysis of tumor protein p53. Alternative splicing of this gene results in three transcript variants encoding three isoforms with different N-termini. Additional transcript variants have been described, but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 4732496B02,5830462N02Rik,A130086L21Rik,ANCR,AS,E6-AP,E6AP ubiquitin-protein ligase,EPVE6AP,HECT-type ubiquitin transferase E3A,HPVE6A,Hpve6a,Human papillomavirus E6-associated protein,Oncogenic protein-associated protein E6-AP,PIX1,Renal carcinoma antigen NY-REN-54,UBE3A,UBE3A-V1,UBE3A-V2,UBE3A-V3,UBE3A-V4,UBE3A-V5,Ube3a,Ubiquitin-protein ligase E3A
Go
to UBE3A products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T87376-Ag-1/ GM-Tg-hg-T87376-Ag-2 | Human UBE3A protein | Human |
| GM-Tg-rg-T87376-Ag-1/ GM-Tg-rg-T87376-Ag-2 | Rat UBE3A protein | Rat |
| GM-Tg-mg-T87376-Ag-1/ GM-Tg-mg-T87376-Ag-2 | Mouse UBE3A protein | Mouse |
| GM-Tg-cynog-T87376-Ag-1/ GM-Tg-cynog-T87376-Ag-2 | Cynomolgus/Rhesus macaque UBE3A protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T87376-Ag-1/ GM-Tg-felg-T87376-Ag-2 | Feline UBE3A protein | Feline |
| GM-Tg-cang-T87376-Ag-1/ GM-Tg-cang-T87376-Ag-2 | Canine UBE3A protein | Canine |
| GM-Tg-bovg-T87376-Ag-1/ GM-Tg-bovg-T87376-Ag-2 | Bovine UBE3A protein | Bovine |
| GM-Tg-equg-T87376-Ag-1/ GM-Tg-equg-T87376-Ag-2 | Equine UBE3A protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T87376-Ag-1/ GM-Tg-hg-T87376-Ag-2;
GM-Tg-rg-T87376-Ag-1/ GM-Tg-rg-T87376-Ag-2;
GM-Tg-mg-T87376-Ag-1/ GM-Tg-mg-T87376-Ag-2; GM-Tg-cynog-T87376-Ag-1/ GM-Tg-cynog-T87376-Ag-2; GM-Tg-felg-T87376-Ag-1/ GM-Tg-felg-T87376-Ag-2; GM-Tg-cang-T87376-Ag-1/ GM-Tg-cang-T87376-Ag-2; GM-Tg-bovg-T87376-Ag-1/ GM-Tg-bovg-T87376-Ag-2; GM-Tg-equg-T87376-Ag-1/ GM-Tg-equg-T87376-Ag-2 |
| Products Name | UBE3A protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | UBE3A |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UBE3A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.